Hints and tips:
Related Special Reports
Companies have yet to provide investors with convincing post-pandemic strategies
...That was until this month, when CVS Caremark, one of three dominant PBMs, dropped Humira from its lists of preferred drugs for reimbursement....
High costs and concerns over efficacy and side effects limit uptake of first treatment as another nears approval
...The writer is a science commentator Should a corporate figure hold the purse strings for publicly funded UK science?...
...Big drugstore chains including CVS and Walgreens Boots have attempted to boost jab uptake....
...Rather he acquired shares of another life sciences company Incyte. Its shares jumped 8 per cent on the Medivation deal. Panuwat quickly cashed out Incyte call options for a $100,000 profit....
Millions of Paxlovid pills have gone unused as tight controls restrict access
Doubts grow over safety and effectiveness of drugs that were marketed as coronavirus treatments
...This is just one character skill the Wharton professor believes can unlock an individual’s potential to do greater things than their background, CV or experience might suggest....
Regulator authorises treatment for sickle cell disease and beta thalassaemia
...WhatsApp to Susan: OK look there’s a chance Labour’s shadow health or science secretaries may drop into these meetings so we can’t just ask the usual types. We need expertise....
...“Anyone who is pulling away today is turning away from the science and responding to political and ideological pressure that is not based on facts, not based on science,” Kerry said....
...It can provide a record of a job well done to make a case for a pay rise or promotion, or for adding detail when staff are updating their CV or LinkedIn profiles....
...“This is a legal battle, but it’s a PR battle in many ways,” said Ana Santos Rutschman, a law professor at Villanova University in the US state of Pennsylvania, who is an expert in life sciences intellectual...
...A version of this article was first published by Nikkei Asia on February 12. ©2024 Nikkei Inc. All rights reserved....
...It also paid $4.9bn this month for Alpine Immune Sciences, which is developing a treatment for an autoimmune kidney disease....
...Earlier this year, CVS Health spent nearly $20bn to acquire home health provider Signify Health and primary care network provider Oak Street Health....
...CVS Health, the largest pharmacy chain in the US, in 2018 acquired Aetna for $69bn and Cigna combined with Express Scripts in a $67bn deal, including debt....
...Given your briefs in health and science, I just wanted to give you an early sight of a paper we are putting out — an AI manifesto for the NHS. We’ve called it Help is on the WAI....
...and engineering, and nuclear science and engineering....
...In the meantime, we are entering a world of massive productivity growth that “is no longer science fiction — we are already in it,” he says....
...Biotech beauty products are increasingly filling our bathroom cabinets; the science may have been used in a simple way for decades, but new innovations are driving considerable change....
Big-selling molnupiravir treatment produces permanent mutations that can be passed from patient to patient
...However, she has since struggled with weakening vaccine demand, rising retail competition and wavering consumer spending, which have also weighed on rival CVS Health....
...communities have provided exactly that context and been a tremendous force for good: they have created and catalyzed global movements, including campaigning for net neutrality in 2015, starting the March for Science...
International Edition